Dolly Aguilera, MD
Enriched profileAssistant Professor of Pediatrics, Peds Neuro-Oncology (Emory University) · Emory University
Dolly Aguilera is Assistant Professor of Pediatrics, Peds Neuro-Oncology (Emory University) at Emory University. OpenAlex indexes 110 publications with 1,536 citations (h-index 22); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 27 Oct 2026
Overview
Updated 28 Oct 2026
Dolly Aguilera, MD, is Assistant Professor of Pediatrics, Peds Neuro-Oncology (Emory University). The public record shows 110 publications with 1,536 citations (h-index 22), centered on Glioma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Sarcoma Diagnosis and Treatment. It also documents an investigator role on 2 registered clinical trials.
- Top research focus: Glioma Diagnosis and Treatment
- 2 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 28 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 34.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 28 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Sponsor: National Cancer Institute (NCI)
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 28 Oct 2026
9 congress contributions (2007–2024) across AACR, ASCO per OpenAlex. The most recent:
- Abstract B065: A phase 1 study of abemaciclib, a CDK 4/6 inhibitor, with radiation in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)
AACR (meeting unresolved)
AACR2024Co-author - Window-of-opportunity study of ONC201 in pediatric patients with diffuse intrinsic pontine glioma (DIPG) and thalamic glioma.
ASCO Annual Meeting
ASCO2022Co-authorPosterTrials in progress
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma
Journal of Clinical Oncology
2024 - Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions
Clinical Cancer Research
2024
Most-cited works
by citation count (OpenAlex)- 01
- 02ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline GliomaArticle120 citations2024
- 03
- 04
- 05The rationale for targeted therapies in medulloblastomaReview66 citations2013
Network
Updated 28 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 28 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
med.emory.edu/departments/pediatrics/divisions/hematology/profile
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.emory.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 28 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Pontificia Universidad Javeriana (medical school)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →choa.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →choa.org ↗
- Aflac Cancer and Blood Disorders Center
Scottish Rite (Children's Healthcare of Atlanta)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →choa.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
James Lah, MD
Emory University
Keith Delman, MD
Emory University
John Puskas, MD
Emory University
Jack Arbiser, MD
Emory University
Guy McKhann, MD
Emory University School of Medicine
Patrick Wen, MD
Dana-Farber Cancer Institute
Minesh Mehta, MD
Florida International University Herbert Wertheim College of Medicine
Timothy Cloughesy, MD
Ronald Reagan UCLA Medical Center